Company intelligence / Profile preview
Oshadi Drug Administration Ltd.
Zerifin, Israel
- Ownership
- Private
- Development stage
- Other
01
Overview
Oshadi Drug Administration Ltd. is an Israeli biotech/pharmaceutical company focused on developing oral formulations of biologics using proprietary nanoparticle carriers. Its lead programs included an oral DNase therapy for oncology indications and an oral insulin product for diabetes. Several clinical trials were initiated between ~2013–2018 but have since been suspended or completed with no further development reported after mid–2018. The company’s current operational status is unclear.
- Therapeutic areas
- OncologyEndocrinology
- Modalities
- Small molecules (oral insulin, DNase formulations)Nanoparticle drug delivery systemsPeptides/proteins (insulin, proinsulin, C-peptide)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Oshadi Drug Administration Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oshadi Drug Administration Ltd..